Nanobodies are engineered antibodies that have a single domain developed by heavy chains with antigen–binding. These antibodies can be engineered and are suitable for various applications for research, therapeutic development, and medical diagnosis due to their size and single-chain nature. Nanobodies have various interesting applications including research on clinical therapeutics. Nanobodies are extensively used in the field of diagnosis and research, and it plays a crucial role and has great potential in noninvasive in vivo imaging. Nanobodies meet requirements to become a generic imaging tracer and offer benefits in molecular imaging, which leads to an increase in the use of nanobodies.
Market Dynamics
Market players are indulged in research and development activities for advancement of nanobodies for therapeutical treatments, which is expected to drive the growth of the global nanobodies market over the forecast period. For instance, according to an article published on Nature Journal on December 21, 2020, researchers at National Institutes of Health isolated a set of nanobodies against SARS-CoV-2. This nanobody is called NIH-CoVnb-112, which binds and blocks the variant form of SARS-Cov-2 spike protein.
Increasing awareness about early diagnosis as well as treatment is expected to drive the growth of the global nanobodies market over the forecast period. For instance, in October 2020, the Government Royapettah Hospital (GRH) organized an awareness program on breast cancer in India. This enabled to increase early detection, diagnosis, and availability of advanced technologies to improve survival rate of patients. This program aimed to create awareness about breast cancer and prevention at an early stage through early detection to avoid further consequences. By using nanobodies, which work as substitutes for naturally occurring antibodies for cancer treatment, they bind to the antigens on the surface of cancer cells, which helps to detect the cancer cells and block their growth. This can help in reducing the prevalence of cancer.
Key features of the study:
- This report provides an in-depth analysis of global nanobodies market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global nanobodies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Merck KGaA, Sanofi (Ablynx), Alphamab Oncology, Novartis AG, Genscript, Taisho Pharmaceutical Holdings Co., Ltd., Sensei Biotherapeutics, Inc., Cusabio Technology LLC., ChromoTek GmbH, Beroni Group, ExeVir Bio BV, Absolute Antibody, Alpalife (Shenzhen kangti Co., Ltd.), DiosCURE Therapeutics SE, Thermo Fisher Scientific Inc., PerkinElmer Inc. (BioLegend, Inc.), and Abnova Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global nanobodies market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanobodies market
Detailed Segmentation:
- Global Nanobodies Market, By Product Type :
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- Global Nanobodies Market, By Application:
- Global Nanobodies Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Nanobodies Market, By Region:
- North America
- By Product Type:
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- By Application :
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Latin America
- By Product Type:
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- By Application :
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- By Application :
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- By Application :
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- By Application :
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- By Application :
- By Distribution Channel:
- Hospitals pharmacies
- Retails Pharmacies
- Online Pharmacies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Merck KGaA *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi (Ablynx)
- Alphamab Oncology
- Novartis AG
- Genscript
- Taisho Pharmaceutical Holdings Co., Ltd.
- Sensei Biotherapeutics, Inc.
- Cusabio Technology LLC.
- ChromoTek GmbH
- Beroni Group
- ExeVir Bio BV
- Absolute Antibody
- Alpalife (Shenzhen kangti Co., Ltd.)
- DiosCURE Therapeutics SE
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc. (BioLegend, Inc.)
- Abnova Corporation
“*” marked represents similar segmentation in other categories in the respective section.
